Selling pressure saw the shares of Ranbaxy Laboratories witnessing dip of almost 7 per cent in the early trade on the Bombay Stock Exchange.
Ranbaxy Laboratories on Thursday had filed a consent decree with a U.S. court as part of its settlement with the U.S. authorities regarding a ban on certain manufacturing plants operated by the company in India and US.
The shares of the company were trading at 454.85 down 4.18 per cent at 10:00 hours
In a similar fashion, shares of the company were trading at Rs 454.65, down 4.18 per cent on the National Stock Exchange.
Meanwhile, the broader benchmark Sensex was quoting at 17,171.34, up 94.16 points at 10:00 hours
